Impact of the DSP-H1684R Genetic Variant on Ion Channels Activity in iPSC-Derived Cardiomyocytes.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
25 Jul 2020
Historique:
accepted: 16 07 2020
entrez: 25 7 2020
pubmed: 25 7 2020
medline: 13 1 2021
Statut: ppublish

Résumé

Mutations of desmosomal genes are known to cause arrhythmogenic cardiomyopathy characterized by arrhythmias and sudden cardiac death. Previously, we described a novel genetic variant H1684R in desmoplakin gene (DSP), associated with a progressive cardiac conduction disease (PCCD). In the present study, we aimed to investigate an effect of the DSP-H1684R genetic variant on the activity of ion channels. We used cardiomyocytes derived from induced pluripotent stem cells (iPSC cardiomyocytes) from a patient with DSP-H1684R genetic variant and from two healthy donors. Immunofluorescent staining and western blot analyses were used to characterize patient-specific cardiomyocytes. By the whole-cell voltage-clamp technique we estimated the activity of voltage-gated sodium, calcium, and potassium channels that are responsible for action potential generation and its shape. Action potentials' parameters were measured using whole-cell current-clamp technique. In patient-specific cardiomyocytes we observed both lower amplitudes of currents through sodium Na Our results show that desmoplakin genetic variants, besides conduction slowing caused by structural heart remodeling, could affect multiple ion channel activity aggravating arrhythmia manifestation in PCCD.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
Mutations of desmosomal genes are known to cause arrhythmogenic cardiomyopathy characterized by arrhythmias and sudden cardiac death. Previously, we described a novel genetic variant H1684R in desmoplakin gene (DSP), associated with a progressive cardiac conduction disease (PCCD). In the present study, we aimed to investigate an effect of the DSP-H1684R genetic variant on the activity of ion channels.
METHODS METHODS
We used cardiomyocytes derived from induced pluripotent stem cells (iPSC cardiomyocytes) from a patient with DSP-H1684R genetic variant and from two healthy donors. Immunofluorescent staining and western blot analyses were used to characterize patient-specific cardiomyocytes. By the whole-cell voltage-clamp technique we estimated the activity of voltage-gated sodium, calcium, and potassium channels that are responsible for action potential generation and its shape. Action potentials' parameters were measured using whole-cell current-clamp technique.
RESULTS RESULTS
In patient-specific cardiomyocytes we observed both lower amplitudes of currents through sodium Na
CONCLUSION CONCLUSIONS
Our results show that desmoplakin genetic variants, besides conduction slowing caused by structural heart remodeling, could affect multiple ion channel activity aggravating arrhythmia manifestation in PCCD.

Identifiants

pubmed: 32706220
doi: 10.33594/000000249
doi:

Substances chimiques

Calcium Channels 0
Desmoplakins 0
Ion Channels 0
Potassium Channels, Voltage-Gated 0
Voltage-Gated Sodium Channels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

696-706

Subventions

Organisme : Russian Science Foundation
ID : 19-75-00070, 19-14-00114
Pays : Russia
Organisme : Russian Foundation for Basic Research
ID : 17-54-80006
Pays : Russia

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Konstantin Gusev (K)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

Aleksandr Khudiakov (A)

Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.

Anastasia Zaytseva (A)

Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.

Kseniya Perepelina (K)

Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Saint Petersburg State University, St. Petersburg, Russia.

Sofia Makeenok (S)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

Elena Kaznacheyeva (E)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia, evkazn@incras.ru.

Anna Kostareva (A)

Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Karolinska Institute, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH